Skip to main content
. 2022 May 19;327(24):2452–2454. doi: 10.1001/jama.2022.8025

Table 1. Outcomes of Patients With MIS-C in 12 Israeli Hospitals During the Alpha, Delta, and Omicron Waves.

Outcome Alpha wavea (n = 59) Delta wavea (n = 79) Omicron wavea (n = 33)
Cardiac variables
NT-proBNP level, median (IQR), pg/mL 2961 (931-15 900) 2275 (799- 4919) 1068 (435-5933)
Troponin level, median (IQR), ng/L 10 (5-113) 23 (13-57) 55 (25-157)
Reduced left ventricular function, No. (%)b 5 (8.5) 6 (7.6) 1 (3.0)
Length of stay and admission to ICU
Hospital length of stay, median (IQR), d 6 (5-8) 6 (5-8.5) 4 (3-6)
ICU length of stay, median (IQR), d 3 (2-6) 4 (2-6) 4 (2-6)
ICU admission, No. (%) 34 (57.6) 39 (49.4) 7 (21.2)
ICU treatment, No. (%)
Vasopressors 13 (22.0) 14 (17.7) 2 (6.0)
Mechanical ventilation 5 (8.5) 7 (8.9) 0
Extracorporeal membrane oxygenation 0 2 (2.5%) 0

Abbreviations: ICU, intensive care unit; NT-proBNP, N-terminal fragment of the prohormone brain natriuretic peptide.

a

Each wave was a 16-week period: Alpha, December 20, 2020, to April 10, 2021; Delta, July 18, 2021, to November 13, 2021; and Omicron, November 21, 2021, to March 12, 2022.

b

All patients underwent echocardiography within 24 hours of admission. The definition of reduced function was an ejection fraction less than 40%.